| 查看: 371 | 回复: 4 | ||
| 【奖励】 本帖被评价3次，作者jessie7527增加金币 2.5 个 | ||
| 当前主题已经存档。 | ||
[资源]
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
|
||
|
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) By Wei Dai Publisher: Humana Press Number Of Pages: 314 Publication Date: 2008-05-01 ISBN-10 / ASIN: 1588299309 ISBN-13 / EAN: 9781588299307 Binding: Hardcover Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. http://rapidshare.com/files/1120 ... _Cancer_Therapy.pdf |
回复此楼» 猜你喜欢
26调剂 086003
已经有3人回复
-
265求调剂
已经有20人回复
-
271分求调剂学校
已经有11人回复
-
320分人工智能调剂
已经有6人回复
-
求调剂，一志愿南京航空航天大学 ，080500材料科学与工程学硕
已经有8人回复
-
280求调剂
已经有19人回复
-
求材料调剂，一志愿郑州大学289分
已经有15人回复
-
26考研调剂0710 0860
已经有6人回复
-
282求调剂
已经有22人回复
-
283求调剂
已经有5人回复
2楼2008-05-04 13:44:28
3楼2008-05-05 08:43:22
4楼2008-05-06 08:56:51
